Q32 Bio, Inc. (QTTB)
8.65
-0.15
(-1.70%)
USD |
NASDAQ |
Oct 23, 16:00
8.63
-0.02
(-0.23%)
After-Hours: 20:00
Q32 Bio Price : 8.65 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 8.80 | 8.835 | 8.30 | 8.65 | 404053.0 |
| Oct 22, 2026 | 8.67 | 9.01 | 8.60 | 8.80 | 363639.0 |
| Oct 21, 2026 | 8.62 | 8.81 | 8.55 | 8.67 | 322326.0 |
| Oct 20, 2026 | 7.79 | 8.84 | 7.79 | 8.62 | 506472.0 |
| Oct 19, 2026 | 7.52 | 7.94 | 7.52 | 7.79 | 609940.0 |
| Oct 16, 2026 | 7.82 | 7.82 | 7.28 | 7.52 | 678979.0 |
| Oct 15, 2026 | 8.01 | 8.29 | 7.72 | 7.77 | 625386.0 |
| Oct 14, 2026 | 7.93 | 8.30 | 7.72 | 8.01 | 889541.0 |
| Oct 13, 2026 | 8.69 | 8.69 | 7.89 | 8.06 | 719979.0 |
| Oct 12, 2026 | 8.64 | 9.155 | 8.44 | 8.74 | 684593.0 |
| Oct 09, 2026 | 8.125 | 8.46 | 7.94 | 8.34 | 854920.0 |
| Oct 08, 2026 | 7.94 | 8.12 | 7.62 | 8.09 | 860237.0 |
| Oct 07, 2026 | 8.00 | 8.07 | 7.83 | 7.99 | 570154.0 |
| Oct 06, 2026 | 8.32 | 8.36 | 7.80 | 8.11 | 678816.0 |
| Oct 05, 2026 | 8.09 | 8.56 | 7.81 | 8.37 | 955754.0 |
| Oct 02, 2026 | 8.35 | 9.11 | 8.17 | 8.23 | 2.098M |
| Oct 01, 2026 | 8.36 | 8.85 | 7.75 | 8.25 | 3.088M |
| Sep 30, 2026 | 10.40 | 10.40 | 7.878 | 8.27 | 5.251M |
| Sep 29, 2026 | 9.32 | 9.665 | 9.164 | 9.53 | 918140.0 |
| Sep 28, 2026 | 9.21 | 9.445 | 8.77 | 9.23 | 1.005M |
| Sep 25, 2026 | 9.20 | 9.20 | 8.74 | 8.77 | 515625.0 |
| Sep 24, 2026 | 9.51 | 9.55 | 9.05 | 9.22 | 1.075M |
| Sep 23, 2026 | 10.58 | 10.58 | 9.50 | 9.56 | 828917.0 |
| Sep 22, 2026 | 10.60 | 10.99 | 10.53 | 10.57 | 387173.0 |
| Sep 21, 2026 | 10.57 | 10.75 | 10.30 | 10.47 | 359558.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 11.21 |
| Beam Therapeutics, Inc. | 24.05 |
| Prime Medicine, Inc. | 3.67 |
| Prelude Therapeutics, Inc. | 3.63 |
| Twist Bioscience Corp. | 139.92 |
Price Related Metrics
| PE Ratio | 2.882 |
| PS Ratio | 2.385 |
| Price to Book Value | 1.939 |
| Earnings Yield | 34.70% |
| Market Cap | 205.32M |
| Operating PE Ratio | 5.972 |
| Normalized PE Ratio | 2.877 |